Literature DB >> 9700050

Autoantibodies to components of the mitotic apparatus.

J B Rattner1, G J Mack, M J Fritzler.   

Abstract

Autoantibodies directed to a variety of cellular antigens and organelles are a feature of autoimmune diseases. They have proven useful in a clinical setting to establish diagnosis, estimate prognosis, follow disease progression, alter therapy, and initiate new investigations. Cellular and molecular biologists have used autoantibodies as probes to identify molecules involved in key cellular processes. One of the most interesting sets of autoantibodies are those that target antigens within the mitotic apparatus (MA). The MA includes chromosomes, spindle microtubules and centrosomes. The identification, localization, function, and clinical relevance of MA autoantigens is the focus of this review.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9700050     DOI: 10.1023/a:1016523013819

Source DB:  PubMed          Journal:  Mol Biol Rep        ISSN: 0301-4851            Impact factor:   2.316


  108 in total

1.  CENP-C, an autoantigen in scleroderma, is a component of the human inner kinetochore plate.

Authors:  H Saitoh; J Tomkiel; C A Cooke; H Ratrie; M Maurer; N F Rothfield; W C Earnshaw
Journal:  Cell       Date:  1992-07-10       Impact factor: 41.582

2.  Outcome of systemic lupus erythematosus. A study of 66 patients over 7 years with special reference to the predictive value of anti-DNA antibody determinations.

Authors:  M Gripenberg; T Helve
Journal:  Scand J Rheumatol       Date:  1991       Impact factor: 3.641

3.  Three human chromosomal autoantigens are recognized by sera from patients with anti-centromere antibodies.

Authors:  W Earnshaw; B Bordwell; C Marino; N Rothfield
Journal:  J Clin Invest       Date:  1986-02       Impact factor: 14.808

4.  Identification and characterization of a protein associated with the stembody using autoimmune sera from patients with systemic sclerosis.

Authors:  B Kingwell; M J Fritzler; J Decoteau; J B Rattner
Journal:  Cell Motil Cytoskeleton       Date:  1987

5.  Anticentriolar autoantibodies in children with central nervous system manifestations of Mycoplasma pneumoniae infection.

Authors:  N Cimolai; D Mah; E Roland
Journal:  J Neurol Neurosurg Psychiatry       Date:  1994-05       Impact factor: 10.154

6.  Clinical relevance and HLA association of autoantibodies against the nucleolus organizer region (NOR-90).

Authors:  T Dick; R Mierau; R Sternfeld; E M Weiner; E Genth
Journal:  J Rheumatol       Date:  1995-01       Impact factor: 4.666

7.  Nucleolar transcription factor hUBF contains a DNA-binding motif with homology to HMG proteins.

Authors:  H M Jantzen; A Admon; S P Bell; R Tjian
Journal:  Nature       Date:  1990-04-26       Impact factor: 49.962

8.  Anti-NOR 90. A new autoantibody in scleroderma that recognizes a 90-kDa component of the nucleolus-organizing region of chromatin.

Authors:  J L Rodriguez-Sanchez; C Gelpi; C Juarez; J A Hardin
Journal:  J Immunol       Date:  1987-10-15       Impact factor: 5.422

9.  The cell proliferation-associated protein Ki-67 is a target of autoantibodies in the serum of MRL mice.

Authors:  D B Bloch; D Rabkina; K D Bloch
Journal:  Lab Invest       Date:  1995-09       Impact factor: 5.662

10.  Analysis of the autoantibody response to fibrillarin in human disease and murine models of autoimmunity.

Authors:  K Takeuchi; S J Turley; E M Tan; K M Pollard
Journal:  J Immunol       Date:  1995-01-15       Impact factor: 5.422

View more
  6 in total

1.  Heterochromatic deposition of centromeric histone H3-like proteins.

Authors:  S Henikoff; K Ahmad; J S Platero; B van Steensel
Journal:  Proc Natl Acad Sci U S A       Date:  2000-01-18       Impact factor: 11.205

2.  Antinuclear Antibody-Negative Systemic Lupus Erythematosus in an International Inception Cohort.

Authors:  May Y Choi; Ann E Clarke; Yvan St Pierre; John G Hanly; Murray B Urowitz; Juanita Romero-Diaz; Caroline Gordon; Sang-Cheol Bae; Sasha Bernatsky; Daniel J Wallace; Joan T Merrill; David A Isenberg; Anisur Rahman; Ellen M Ginzler; Michelle Petri; Ian N Bruce; Mary A Dooley; Paul R Fortin; Dafna D Gladman; Jorge Sanchez-Guerrero; Kristjan Steinsson; Rosalind Ramsey-Goldman; Munther A Khamashta; Cynthia Aranow; Graciela S Alarcón; Susan Manzi; Ola Nived; Asad A Zoma; Ronald F van Vollenhoven; Manuel Ramos-Casals; Guillermo Ruiz-Irastorza; S Sam Lim; Kenneth C Kalunian; Murat Inanc; Diane L Kamen; Christine A Peschken; Soren Jacobsen; Anca Askanase; Thomas Stoll; Jill Buyon; Michael Mahler; Marvin J Fritzler
Journal:  Arthritis Care Res (Hoboken)       Date:  2019-06-12       Impact factor: 4.794

3.  Antibodies to mitotic spindle apparatus: clinical significance of NuMA and HsEg5 autoantibodies.

Authors:  Lourdes Mozo; Carmen Gutiérrez; Jesús Gómez
Journal:  J Clin Immunol       Date:  2008-02-01       Impact factor: 8.317

4.  RHAMM is a centrosomal protein that interacts with dynein and maintains spindle pole stability.

Authors:  Christopher A Maxwell; Jonathan J Keats; Mary Crainie; Xuejun Sun; Tim Yen; Ellen Shibuya; Michael Hendzel; Gordon Chan; Linda M Pilarski
Journal:  Mol Biol Cell       Date:  2003-03-20       Impact factor: 4.138

5.  Clinical relevance of HEp-2 indirect immunofluorescent patterns: the International Consensus on ANA patterns (ICAP) perspective.

Authors:  Jan Damoiseaux; Luis Eduardo Coelho Andrade; Orlando Gabriel Carballo; Karsten Conrad; Paulo Luiz Carvalho Francescantonio; Marvin J Fritzler; Ignacio Garcia de la Torre; Manfred Herold; Werner Klotz; Wilson de Melo Cruvinel; Tsuneyo Mimori; Carlos von Muhlen; Minoru Satoh; Edward K Chan
Journal:  Ann Rheum Dis       Date:  2019-03-12       Impact factor: 19.103

6.  Uncommon patterns of antinuclear antibodies recognizing mitotic spindle apparatus antigens and clinical associations.

Authors:  Juan Felipe Betancur; Adriana Londoño; Victoria Eugenia Estrada; Sandra Liliana Puerta; Sandra Marcela Osorno; Angela Loaiza; Jenny Andrea Carmona; José Alfredo Gómez-Puerta
Journal:  Medicine (Baltimore)       Date:  2018-08       Impact factor: 1.817

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.